Cargando…

Is closer linkage between systemic lupus erythematosus and anti-double-stranded DNA antibodies a desirable and attainable goal?

The anti-double-stranded DNA (anti-dsDNA) antibody test incorporated in the 1982 revised American College of Rheumatology criteria for the classification of systemic lupus erythematosus needs updating to reflect current insights and technical achievements, including allowance for the presence of non...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nossent, Hans C, Rekvig, Ole Petter
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1065341/ https://www.ncbi.nlm.nih.gov/pubmed/15743494 http://dx.doi.org/10.1186/ar1707

Ejemplares similares

Fulfilment of fertility desires for the attainment of Global Sustainable Development Goals
por: Mburu, Gitau, et al.
Publicado: (2023)

Systemic Lupus Erythematosus: Definitions, Contexts, Conflicts, Enigmas
por: Rekvig, Ole Petter
Publicado: (2018)

Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis
por: Becker-Merok, Andrea, et al.
Publicado: (2006)

Adapting the Goal Attainment Approach for Major Depressive Disorder
por: McCue, Maggie, et al.
Publicado: (2019)

The dsDNA, Anti-dsDNA Antibody, and Lupus Nephritis: What We Agree on, What Must Be Done, and What the Best Strategy Forward Could Be
por: Rekvig, Ole Petter
Publicado: (2019)

Glomerular matrix metalloproteinases and their regulators in the pathogenesis of lupus nephritis
por: Tveita, Anders, et al.
Publicado: (2008)

Challenging Times for Public Health Towards Attaining Sustainable Development Goals
por: Rao, K Sujatha
Publicado: (2017)

Is prevention of systemic lupus erythematosus a goal?
por: Olsen, Nancy J, et al.
Publicado: (2014)

Renal Dnase1 Enzyme Activity and Protein Expression Is Selectively Shut Down in Murine and Human Membranoproliferative Lupus Nephritis
por: Zykova, Svetlana N., et al.
Publicado: (2010)

β‐cell replacement therapy for type 1 diabetes: closer and closer
por: Jones, Peter M., et al.
Publicado: (2022)

Commentary on "Genetic linkage and transmission disequilibrium of marker haplotypes at chromosome 1q41 in human systemic lupus erythematosus", by RR Graham et al.
por: Barton, Anne C, et al.
Publicado: (2002)

Underdiagnosis of malnutrition in infants and young children in Rwanda: implications for attainment of the Millennium Development Goal to end poverty and hunger
por: Binagwaho, Agnès, et al.
Publicado: (2011)

Discoveries in the pathophysiology of neuropsychiatric lupus erythematosus: consequences for therapy
por: Gono, Takahisa, et al.
Publicado: (2013)

Autoimmunity and SLE: Factual and Semantic Evidence-Based Critical Analyses of Definitions, Etiology, and Pathogenesis
por: Rekvig, Ole Petter
Publicado: (2020)

The Anti-DNA Antibodies: Their Specificities for Unique DNA Structures and Their Unresolved Clinical Impact—A System Criticism and a Hypothesis
por: Rekvig, Ole Petter
Publicado: (2022)

SLE classification criteria: Science-based icons or algorithmic distractions – an intellectually demanding dilemma
por: Rekvig, Ole Petter
Publicado: (2022)

Systemic lupus erythematosus and cardiovascular disease
por: Ruilope, Luis M., et al.
Publicado: (2020)

Attaining Goals Through Partnerships
por: Ramirez, Julio J.
Publicado: (2003)

Recurrent podocytopathy in a patient with systemic lupus erythematosus
por: Paramalingam, Shereen, et al.
Publicado: (2017)

SLE – Hematopoietic stem cell transplantation for systemic lupus erythematosus
por: Burt, Richard K, et al.
Publicado: (2003)

In-/off-label use of biologic therapy in systemic lupus erythematosus
por: Gatto, Mariele, et al.
Publicado: (2014)

Necrotizing fasciitis associated with systemic lupus erythematosus in a child
por: Al-Mendalawi, Mahmood Dhahir
Publicado: (2016)

Commentary: Systemic lupus erythematosus retinopathy: Eye or multisystem involvement?
por: Murugan, Sivaraman Bala, et al.
Publicado: (2023)

Performance Characteristics of Different Anti-Double-Stranded DNA Antibody Assays in the Monitoring of Systemic Lupus Erythematosus
por: Mahler, Michael, et al.
Publicado: (2017)

Getting closer to the goal by being less capable
por: Manrique, Pedro D., et al.
Publicado: (2019)

Balancing diversity and tolerance: lessons from patients with systemic lupus erythematosus
por: Jacobi, Annett M., et al.
Publicado: (2005)

IFN-gamma transgenic mice: clues to the pathogenesis of systemic lupus erythematosus?
por: Seery, John P
Publicado: (2000)

Cohort profile: systemic lupus erythematosus in Sweden: the Swedish Lupus Linkage (SLINK) cohort
por: Arkema, Elizabeth V, et al.
Publicado: (2015)

Which Dendrimer to Attain the Desired Properties? Focus on Phosphorhydrazone Dendrimers†
por: Caminade, Anne-Marie, et al.
Publicado: (2018)

Lupus low disease activity state attainment in the phase 3 TULIP trials of anifrolumab in active systemic lupus erythematosus
por: Morand, Eric F, et al.
Publicado: (2023)

Hypocomplementemia as a Risk Factor for Organ Damage Accrual in Patients with Systemic Lupus Erythematosus
por: Raymond, Warren, et al.
Publicado: (2018)

Endothelio-hematopoietic relationship: getting closer to the beginnings
por: Gordon-Keylock, Sabrina, et al.
Publicado: (2011)

Chromatin as a target antigen in human and murine lupus nephritis
por: Hedberg, Annica, et al.
Publicado: (2011)

Efficacy and Safety of Subcutaneous Belimumab in Anti–Double‐Stranded DNA–Positive, Hypocomplementemic Patients With Systemic Lupus Erythematosus
por: Doria, A., et al.
Publicado: (2018)

B cells, BAFF/zTNF4, TACI, and systemic lupus erythematosus
por: Dörner, Thomas, et al.
Publicado: (2001)

SLE - Systemic lupus erythematosus: a BLySful, yet BAFFling, disorder
por: Stohl, William
Publicado: (2003)

SLE - Practical and theoretical barriers to the prevention of accelerated atherosclerosis in systemic lupus erythematosus
por: Costenbader, Karen H, et al.
Publicado: (2003)

Safer ventilation of the injured lung: one step closer
por: Marini, John J
Publicado: (2010)

DNA vaccines: Getting closer to becoming a reality
por: Bharati, Kaushik, et al.
Publicado: (2013)

Pathogenesis and biomarkers for necrotizing enterocolitis: Getting any closer?
por: Nguyen, Duc Ninh, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ufjfav8mjft3v7v34ngfa5719v